Cargando…
Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies
Inflammation of the GI tract leads to compromised epithelial barrier integrity, which increases intestine permeability. A compromised intestinal barrier is a critical event that leads to microbe entry and promotes inflammatory responses. Inflammatory bowel diseases that comprise Crohn’s disease (CD)...
Autores principales: | Raj, Vishnu, Venkataraman, Balaji, Ojha, Shreesh K., Almarzooqi, Saeeda, Subramanian, Veedamali S., Al-Ramadi, Basel K., Adrian, Thomas E., Subramanya, Sandeep B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096091/ https://www.ncbi.nlm.nih.gov/pubmed/37049744 http://dx.doi.org/10.3390/molecules28072982 |
Ejemplares similares
-
Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models
por: Raj, Vishnu, et al.
Publicado: (2020) -
Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
por: Venkataraman, Balaji, et al.
Publicado: (2021) -
Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation
por: Venkataraman, Balaji, et al.
Publicado: (2023) -
α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study
por: Venkataraman, Balaji, et al.
Publicado: (2022) -
β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways
por: Almarzooqi, Saeeda, et al.
Publicado: (2022)